$361.000 value
$173.00 (15%
off)VIPapplied$361.000
Quantitative "AI stock forecast" models highlight biotech AI firms in pre-clinical drug development as potential outliers, anticipating 18% valuation upticks. Broader tailwinds in artificial intelligence (AI) also gave the stock a boost. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab) . The newest "AI stock forecast" shows Tesla (TSLA) might recover toward $720 by Q4, fueled by AI-based autonomous driving advancements and battery data optimization.
Offers & perks
Join Star Rewards & get
free shipping at $39
Exclusions